Advanced search
Start date

Evaluation of effectiveness of treatment of chronic hepatitis C in real life in retrospective and prospective studies: management trials, development plans, data analysis and socio-economic approaches

Grant number: 14/00058-1
Support type:Scholarships abroad - Research
Effective date (Start): June 01, 2014
Effective date (End): July 31, 2014
Field of knowledge:Health Sciences - Collective Health - Epidemiology
Principal researcher:Norma Suely de Oliveira Farias
Grantee:Norma Suely de Oliveira Farias
Host: Fabrice Carrat
Home Institution: Centro de Vigilância Epidemiológica Alexandre Vranjac (CVE). Coordenadoria de Controle de Doenças (CCD). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil
Research place: Institut National de la Santé et de la Recherche Médicale (Inserm), France  


The goal of the project research fellowship abroad is to incorporate methodological knowledge in the organization and management aimed at evaluating the effectiveness of treatment of hepatitis C (HCV) in conditions of real life trials and further scientific collaboration with the Agence Nationale de Recherche sur le Sida et les Hépatites Virales - ANRS and INSERM, France. Since the late 90s, the Secretary of Health of São Paulo (SES - SP) and the Health Ministry in line with the international literature have established protocols to treat chronic hepatitis C (HCV). Several studies evaluating the effectiveness of alfapeguinterferona and ribavirin in terms of "real life" conducted in other countries have shown similar responses to those reported in clinical trials phase 3. Design Retrospective cohort study supported by the Research Support Foundation of the State of São Paulo - FAPESP is currently under development in the State of São Paulo , coordinated by the Institute of Tropical Medicine of the USP (researcher in charge) and in collaboration with the Centre Epidemiological Surveillance of SES/SP, which participate as principal investigator, supported the hypothesis that the establishment of a network of care in attention to drug treatment of patients with HCV may have a positive impact on adherence and management of adverse events, contributing best to achieve sustained virologic response. Until then, there was no publications in the literature that evaluate the effectiveness of treatment of HCV in the country, comparing the SVR with the effectiveness of clinical trials, objective specific of this research. The research project to be developed in the research fellowship abroad program may help to deepen the experience that I have been accumulating in the investigation of the effectiveness of treatment of HCV and for the implementation of prospective cohort study aimed at assessing the effectiveness of new drugs in treatment of HCV, such as protease inhibitors, and in view of the ongoing review of the care network services. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list by writing to: